Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Wants To Facilitate Value-Based Discounts For HCV Drugs In Medicaid

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS requests information from hepatitis C manufacturers on how value-based purchasing arrangements might work in Medicaid. Agency also urges state Medicaid directors to relax overly strict coverage requirements for the drugs.

Advertisement

Related Content

US Denials Of HCV Treatment Coverage Rising, Regardless Of Payer Type
Anthem Denies Coverage For Eteplirsen, Citing Lack Of Clinical Efficacy
Medicaid Value Contracts Can Avoid ‘Best Price’ Implications, CMS Says
US Retail Drug Spending Growth Slowing With No New Sovaldis In Sight
Harvoni Rebates In Massachusetts Aim For Access, Not Savings
Cost Pushback Limiting Hepatitis C Drug Utilization
CMS-Run Medicaid Purchasing Pools For High-Cost Drugs Floated In Budget
Medicare Could Explore Bundling Payments For Diabetes, Rheumatoid Arthritis
Are Manufacturers Willing To Do Outcomes-Based Pricing? Payers Are Skeptical
Creative Drug Pricing Hindered By Medicaid Best Price, Stakeholders Say

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078057

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel